EndeavorRx® Prospective Product Registry ("Expedition EndeavorRx")

Status unconfirmed

Conditions studied: ADHD

In brief

The EndeavorRx Prospective Product Registry aims to collect real world data from participants receiving the digital therapeutic, EndeavorRx, under conditions of routine clinical practice.

Key facts

Study ID

NCT05991167

Run by

Akili Interactive Labs, Inc.

People needed

150

Starts

2022-06-01

Expected to finish

2025-12-31

Last updated by the study team

2024-06-27

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Are prescribed EndeavorRx by their healthcare provider as part of routine clinical practice
• Provide informed consent/assent to participate in the registry

You may not qualify if…

• N/A

Where it is running

• Akili Interactive Labs, Inc. — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.